Medtronic is a leading medical device company that develops and manufactures healthcare technologies and therapies to address major health challenges. It operates globally, offering a wide range of innovative solutions.

Positive signals

Sustainalytics rates Medtronic as having a medium ESG risk, reflecting moderate exposure to material ESG issues and reasonable management of those risks as of March 2025.

Medtronic's ESG risk level is assessed as 'medium,' with strong performance in corporate governance and management of ESG issues globally, according to a 2024 independent financial compliance review.

Concerns

Improper payments and kickbacks

Product recalls and legal complaints

Recent lawsuits have alleged that some of Medtronic's products caused severe patient injury, and a whistleblower case unsealed in 2023 alleged that Medtronic bribed officials at a Department of Veterans Affairs Hospital to secure device purchases. Medtronic denies these allegations.

Medtronic paid $8.1 million to the U.S. Department of Justice in 2020 to resolve allegations that it paid kickbacks to a South Dakota neurosurgeon, violating federal anti-kickback statutes.

CRITICAL
Source

False Claims Act allegations related to medical procedures